EGFR and non-small cell lung carcinoma: Beyond these well-characterized EGFR mutations, recent attention has turned to EGFR exon 20 insertion (EGFR20ins)-positive NSCLC, which accounts for 10% to 12% of EGFR-addicted tumors [116,117,118].